🔗 Share this article

Chancellor Reeves has stated she is planning "focused measures to deal with household expense challenges" in the forthcoming Budget.

Speaking to the BBC, she emphasized that lowering price rises is a joint responsibility of both the administration and the central bank.

The UK's inflation rate is projected to be the most elevated among the Group of Seven industrialized countries this year and next.

Potential Energy Bill Measures

Reports indicate the administration could intervene to bring down utility costs, such as by cutting the current 5% level of VAT applied on energy.

Another approach is to lower some of the policy costs presently included in bills.

Budgetary Constraints and Expert Expectations

The administration will receive the next report from the official forecaster, the OBR, on the start of the week, which will reveal how much space there is for such actions.

The expectation from most experts is that Reeves will have to declare tax rises or budget cuts in order to meet her voluntary borrowing rules.

Earlier on the same day, calculations showed there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the more modest range of expectations.

"There's a collective responsibility between the Bank of England and the administration to further reduce some of the sources of inflation," Reeves stated to the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Commitments and International Issues

While a great deal of the focus has been on likely tax rises, the chancellor said the most recent data from the fiscal watchdog had not altered her vow to campaign commitments not to raise tax levels on income tax, VAT or National Insurance.

She blamed an "unpredictable global environment" with rising international and commercial tensions for the fiscal revenue measures, likely to be focused on those "most able to pay."

Global Economic Tensions

Referring to apprehensions about the UK's trade ties with China she said: "Our national security invariably come first."

Last week's statement by Chinese authorities to increase export controls on rare earths and other resources that are essential for high-technology production led US President Donald Trump to propose an extra 100% import tax on imports from China, increasing the prospect of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary labeled China's action "commercial pressure" and "a international production power grab."

Inquired about considering the American proposal to participate in its dispute with the Asian nation, Reeves said she was "extremely troubled" by Chinese measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "harmful for the world economy and causes further obstacles."

"It is my opinion there are sectors where we should confront China, but there are also significant prospects to sell into Chinese markets, including financial services and other sectors of the economy. We've got to achieve that balance right."

The Treasury chief also confirmed she was cooperating with G7 counterparts "on our own critical minerals approach, so that we are less reliant."

Health Service Drug Pricing and Funding

Reeves also acknowledged that the price the NHS spends on pharmaceuticals could increase as a result of ongoing negotiations with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either halting or abandoning operations in the United Kingdom, with some blaming the low prices they are getting.

Last month, the Science Minister said the price the health service spends on drugs would need to go up to stop businesses and pharmaceutical investment departing from the United Kingdom.

Reeves stated to media: "We have seen due to the payment system, that medical research, innovative medicines have not been offered in the UK in the extent that they are in other EU nations."

"The objective is to guarantee that patients getting treatment from the National Health Service are able to obtain the best critical medicines in the globe. And so we are examining all of that, and... looking to attract increased funding into the UK."